Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation

INTRODUCTION: Remdesivir and Dexamethasone represent the cornerstone of therapy for critically ill patients with acute hypoxemic respiratory failure caused by Coronavirus Disease 2019 (COVID-19). However, clinical efficacy and safety of concomitant administration of Remdesivir and Dexamethasone (Rem...

Descripción completa

Detalles Bibliográficos
Autores principales: De Pascale, Gennaro, Cutuli, Salvatore Lucio, Carelli, Simone, Xhemalaj, Rikardo, Rosà, Tommaso, Bello, Giuseppe, Vargas, Joel, Cesarano, Melania, Montini, Luca, Tanzarella, Eloisa Sofia, Pintaudi, Gabriele, Di Muro, Mariangela, Grieco, Domenico Luca, Antonelli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049343/
https://www.ncbi.nlm.nih.gov/pubmed/35482703
http://dx.doi.org/10.1371/journal.pone.0267038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049343/
https://www.ncbi.nlm.nih.gov/pubmed/35482703
http://dx.doi.org/10.1371/journal.pone.0267038

Ejemplares similares